Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
273
datasets available to search
ShareScore release 0.9.0
Dataset results
273 results for “Stroke prevention”
Dataset related to article "ANTIHYPERTENSIVE DRUGS FOR SECONDARY PREVENTION AFTER ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK"
<p>we performed a systematic review and meta-analysis in order to summarize the current evidence on blood pressure (BP)-lowering drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack. We searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials up to January 31, 2020. We included randomized controlled trials comparing any specific BP-lowering drug, as monotherapy or combination, with either a control or another BP-lowering drug. Eight studies that enrolled 33 774 patients with ischemic stroke or transient ischemic attack were included in the meta-analysis. Primary outcomes were all-cause mortality and the proportion of patients who developed a stroke following BP-lowering drug use, irrespective of its nature (ischemic or hemorrhagic) and severity. Secondary outcomes included the proportion of patients who developed an ischemic stroke; an ischemic stroke or TIA irrespective of severity; a hemorrhagic stroke, defined as an acute extravasation of blood into and around the brain parenchyma (subdural hematoma and epidural hematoma were excluded); a cardiovascular event defined as any sudden death, fatal or nonfatal acute coronary syndrome, stroke, intracranial hemorrhage, or pulmonary embolism; a fatal cardiovascular event defined as any death due to any vascular cause, including unexplained sudden death; and serious adverse events of hypotension, syncope, injurious falls, electrolyte abnormalities, bradycardia, or acute renal failure. We recorded the outcomes at the longest available follow-up for all analyses. We considered the following potential sources of heterogeneity (effect modifiers): inclusion limited to hypertensive patients (normotensive and hypertensive patients versus hypertensive patients only) or noncardioembolic ischemic strokes (all ischemic strokes versus noncardioembolic ischemic strokes only), time from the index ischemic event to randomization (acute patients treated within the first week versus stabilized patients treated after the first week), and trial risk of bias.</p>
THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
ClinicalTrials.gov study NCT03354429. IPD Sharing: Not stated. Countries: 28. Publications: 9.
Effects of an Individual and Family Self-Management of Fall Prevention Program on Balance Ability and Fall-related Self-efficacy Among Chinese Post-Stroke Individuals
ClinicalTrials.gov study NCT06577662. IPD Sharing: YES. Countries: 1. Publications: 1.
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
ClinicalTrials.gov study NCT00153062. IPD Sharing: Not stated. Countries: 36. Publications: 8.
Prevent Return of Stroke Study
ClinicalTrials.gov study NCT01027273. IPD Sharing: Not stated. Countries: 1. Publications: 6.
SDM for Stroke Prevention in Atrial Fibrillation
ClinicalTrials.gov study NCT02905032. IPD Sharing: NO. Countries: 1. Publications: 6.
Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis
ClinicalTrials.gov study NCT00576693. IPD Sharing: Not stated. Countries: 1. Publications: 16.
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With No
ClinicalTrials.gov study NCT01493557. IPD Sharing: Not stated. Countries: 2. Publications: 1.
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
ClinicalTrials.gov study NCT03192215. IPD Sharing: YES. Countries: 2. Publications: 13.
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
ClinicalTrials.gov study NCT00412984. IPD Sharing: Not stated. Countries: 41. Publications: 60.
mHealth Screening to Prevent Strokes
ClinicalTrials.gov study NCT02506244. IPD Sharing: NO. Countries: 1. Publications: 4.
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
ClinicalTrials.gov study NCT00494871. IPD Sharing: Not stated. Countries: 1. Publications: 11.
The SUCCEED Trial of Secondary Stroke Prevention
ClinicalTrials.gov study NCT01763203. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
ClinicalTrials.gov study NCT02313909. IPD Sharing: Not stated. Countries: 31. Publications: 15.
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspi
ClinicalTrials.gov study NCT01225562. IPD Sharing: Not stated. Countries: 31. Publications: 22.
DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
ClinicalTrials.gov study NCT02666742. IPD Sharing: NO. Countries: 2. Publications: 2.
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial
ClinicalTrials.gov study NCT05643573. IPD Sharing: NO. Countries: 38. Publications: 2.
Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation
ClinicalTrials.gov study NCT03187197. IPD Sharing: NO. Countries: 1. Publications: 1.
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
ClinicalTrials.gov study NCT00403767. IPD Sharing: Not stated. Countries: 44. Publications: 27.
VITATOPS: A Study of VITAmins TO Prevent Stroke
ClinicalTrials.gov study NCT00097669. IPD Sharing: Not stated. Countries: 20. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.